← All trials
NCT06214572
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 7, 2024
- Primary completion
- Jul 21, 2029
- Completion date
- Jul 21, 2029
- First posted
- Jan 19, 2024
- Last posted
- Apr 11, 2024
- Enrollment
- 249
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tata Memorial HospitalLead sponsor
- Tata Memorial HospitalSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.